A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

Publication | Open Access

DOI Full Paper Access

Citations

References

2015

Year

Seth A. Rosenthal, Daniel Hunt, Oliver Sartor, Kenneth J. Pienta, Leonard G. Gomella, David J. Grignon, Raghu Rajan, K. Kerlin, Christopher U. Jones, M.C. Dobelbower,

International Journal of Radiation Oncology*Biology*Physics

UrologyRadiation MedicineRadiation TherapyMedicineClinical TrialsAdjuvant ChemotherapyProstatic DiseaseOncologyRadiation OncologyAndrogen SuppressionPhase 3Health Sciences